CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 19.25
  • +1.42+7.96%
Market Closed Sep 27 15:00 CST
11.87BMarket Cap36.05P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Guojian Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 23, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
329.72M
--
+21.91%
Net Income
--
35.61M
--
-39.21%
Analyst Rating
Buy

Sep 28, 2024

Sunshine Guojian Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.334B--
--2024/FY-- / 1.263B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.334B--
--2024/FY-- / 1.263B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--

Unlock Free Earnings Estimates

Sunshine Guojian Pharmaceutical Earnings Reports

  • Sunshine Guojian Pharmaceutical: Half-year report for the year 2024.

    Aug 22 12:00 ET

  • Sunshine Guojian Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 22 12:00 ET

  • Sansei Guojian: Report for the first quarter of 2024

    Apr 25 12:00 ET

  • Kokuken Mitsubo: Summary of the 2023 Annual Report

    Mar 20 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 28, 2024

    Buy

    • Strong Buy

      33.33%

    • Buy

      66.67%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data